Department of Pharmaceutical Sciences, College of Pharmacy Howard University Washington DC, Center for Drug Research and Development (CDRD), USA

Publications

• Reviews   
  Nanotechnology in the development of small and large molecule tyrosine kinase inhibitors and immunotherapy for the treatment of HER2-positive breast cancer
  Author(s): Victor Ejigah, Bharathi Mandala and Emmanuel O Akala*

  • Abstract
  • Full-Text
  • PDF